Friday, 31 August 2012

Lifetime hip replacements

A team of biologists, nanoengineers and surgeons from Glasgow University has come up with a technique that could produce hip replacements that last a lifetime. At the moment a patient is lucky if their replacement lasts 15 years because it wears away so quickly, especially now more younger patients are receiving them who tend to be more active.

The researchers made the discovery that by controlling the pattern on the surface of the joint they could control what type of tissue forms there. This means it would be possible to encourage stem cells to form new bone in contact with the joint by coating the key surfaces in a "nanopattern" pitted plastic. This system aims to avoid the problem of soft tissues forming around the hip replacements which can cause them to come loose, instead the bone that forms will prevent this problem by keeping a much tighter grip on the joint.

The next step would be to coat the key surfaces of an implant with the pattern and carry out some human trials, this means it will likely be five or maybe ten years before the technology is used in the operating theatre. However it should be well worth the wait as it could also be useful in knee and shoulder replacements, and the nanopattern may even have applications in new drugs to combat osteoporosis.

Jack

Saturday, 25 August 2012

Drug can 'disarm' harmful bacteria

Researchers at the University of Montreal have discovered a way to 'disarm' hostile bacteria which then allows the body's own immune system to destroy them as an alternative to killing the bacteria outright with antibiotics.

Dr. Christian Baron, Professor at the Department of Biochemistry, said that the drug they had developed would remove the bacteria's virulence factors (the things that make some bacteria harmful to us) therefore rendering them harmless and vulnerable to attack from our immune system.

The finding came about during their research into a type of pathogenic bacteria called Brucella when Baron's team discovered small molecules that target proteins in a biological system which are required for many bacteria to be harmful.

This method of killing bacteria to stop infection in patients is welcome news as nowadays there are many forms of antibiotic resistant bacteria that evolved as a result of antibiotic overuse. However if these anti-virulence drugs become widely used in place of antibiotics they should not lose their effectiveness just as antibiotics did, Dr. Baron claims that the development of resistance to them would be slow or might not even occur at all. In addition to this we now understand how resistant bacteria can come about so we can prevent resistance to this type of drug by only prescribing them when they are really necessary.

Unfortunately no human trials on anti-virulence drugs have yet been carried out so it will be a while before they become widely available and doctors are able to prescribe them to patients.

Jack

Friday, 17 August 2012

AS Results

Yesterday morning like many other anxious 17 year olds across the country I received my AS results which will help to determine what I'll go on to do next year.

Naturally I was pleased to find out that I'd achieved ABBB in Maths, Chemistry, Human Biology and Psychology respectively. If I'm able to replicate this success in a year's time with my A level results for Maths, Chemistry and Human Biology (as I intend to drop Psychology) I should be in a good position to get on a Biochemistry course.

I also hope to increase my Human Biology grade to an A which will mean I'll meet the requirements for a wider range of universities and give me an even greater choice of where I study. But at the moment even ABBb equates to 370 UCAS points which is more than enough for some of the universities I've looked at, and I can add onto that the points I get for completing the Extended Project Qualification, provided the University recognises it.

For now though I'll continue preparing my UCAS application and looking into some more universities that I haven't considered yet before I decide which five to apply to.

Jack

Thursday, 16 August 2012

Prostate drug approved in Scotland

Abiraterone, a drug that can extend the lives of men with incurable prostate cancer, has been approved for use in Scotland, the last part of the UK to make it available on the NHS.

The disease, which kills 10,000 men a year, is the second most common cause of cancer deaths in UK men.

The Scottish Medicines Consortium (SMC) had previously rejected a submission to allow the drug to be used in Scotland as they believed the cost of £3,000 a month did not justify the health benefits. However after reversing it's initial decision the SMC has decided to restrict the drug to patients who have only received one chemotherapy regime.

The verdict has been welcomed by cancer charities such as Prostate Cancer UK whose chief executive, Owen Sharp, was pleased at the decision. He said "Today brings a victory for both decency and common sense. Abiraterone has now been approved for use on the NHS UK-wide and I thank and congratulate everyone who backed us and helped us achieve this result." Also Dr Harpal Kumar, chief executive at Cancer Research UK, commented that although Abiraterone is not a cure, it can provide men with crucial extra months at the end of their lives.

Now that doctors across the whole of the UK are able to prescribe the drug to men with prostate cancer, it can give hope to sufferers of the disease by giving them the time to do what they want before they die.

Jack

Friday, 3 August 2012

'Spray-on-skin' heals wounds

According to US and Canadian researchers a "spray-on-skin" that coats wounds in a layer of skin cells and blood-clotting proteins could help the healing process.

A study was conducted on 228 people suffering from leg ulcers, painful open wounds that can last for months, and it was found that the ulcers which were treated with the spray had a higher chance of healing, and those that did took less time to do so.

If this treatment became widely available it would be a welcome break to those who suffer from leg ulcers as it was found to be more effective than other treatments including the current most effective, compression bandages, and skin grafts that are taken from other areas of the patient's body. 70% of those treated with the spray were healed after 3 months compared to 46% of the people who received other treatments, and the biggest improvements were in the patients who were given the spray every 14 days.

The treatment would also be preferable to skin grafting as the spray can be available to use whenever needed, whereas skin grafts take time to create which puts the patients in more discomfort and leaves them vulnerable to infection. As well as this the fact that no skin needs to be taken from the patient means they won't be left with a scar on another part of their body.

Although this treatment does not address the underlying cause of leg ulcers so they are not prevented from happening again, it does improve short-term healing which in my mind justifies the cost.

Jack